Protocol summary

Study aim
To determine and compare early surgical site infection (SSI), intra-abdominal abscess rate, net cost, and postoperative quality of life between open and laparoscopic appendectomy.
Design
Randomized, parallel group, single-blind (data analyst), phase 3 clinical trial in 2025 across all hospitals in Kerman; 162 patients, simple randomization using A/B card draw.
Settings and conduct
The trial will be conducted in 2025 across all hospitals in Kerman. Patients (Alvarado score >5) will be randomized into two groups. Only the data analyst will be blinded. Consent obtained, confidentiality maintained.
Participants/Inclusion and exclusion criteria
Patients aged 15–60 with uncomplicated acute appendicitis, no systemic disease or coagulation disorder, and signed informed consent will be included.
Intervention groups
Both groups undergo appendectomy under general anesthesia by a unified surgical team. Group 1: Open surgery; Group 2: Three-port laparoscopic surgery. Closure and protocols are standardized.
Main outcome variables
Patients will be assessed on days 1, 2, 3, 7, and 14 after surgery for the occurrence of surgical site infection (SSI). The evaluated signs include redness at the incision site; purulent discharge; pain and swelling; fever; and culture results of the discharge in suspected cases. Additionally, the formation of intra-abdominal abscess will be evaluated using abdominal ultrasound. Other variables to be assessed include duration of surgery (minutes); length of hospital stay (days); consumption of opioid analgesics after surgery; and quality of life assessment during the first week post-surgery using the standardized WHO-QOL-BREF questionnaire.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20250507065635N1
Registration date: 2025-10-01, 1404/07/09
Registration timing: registered_while_recruiting

Last update: 2025-10-01, 1404/07/09
Update count: 0
Registration date
2025-10-01, 1404/07/09
Registrant information
Name
Fatemeh Doost Mohammadi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 34 3244 1553
Email address
f.doostmohammadi2@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2025-08-23, 1404/06/01
Expected recruitment end date
2025-12-21, 1404/09/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of Laparoscopic Appendectomy Vs Open Appendectomy concerning Early Surgical Site Infection Incidence, Single-Blinded Parallel-Group, Randomized Controlled Trial
Public title
Laparoscopic vs. Open Appendectomy: Surgical Site Infection Study
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
All patients with acute appendicitis and an Alvarado score greater than five will be included in the study.
Exclusion criteria:
Age
From 10 years old to 65 years old
Gender
Both
Phase
N/A
Groups that have been masked
  • Data analyser
  • Data and Safety Monitoring Board
Sample size
Target sample size: 162
Randomization (investigator's opinion)
Randomized
Randomization description
Patients will be randomly assigned to either open or laparoscopic surgery using simple randomization. To this end, cards containing the letters A or B will be placed in identical envelopes, and one card will be randomly selected for each participant. If the letter A is drawn, the participant will be assigned to the open appendectomy group, and the next participant will be assigned to the laparoscopic appendectomy group. If the letter B is drawn, the participant will be assigned to the laparoscopic appendectomy group, and the next participant will be assigned to the open appendectomy group.
Blinding (investigator's opinion)
Single blinded
Blinding description
Patients will be blinded to the type of surgery (open/laparoscopic) only before the procedure, and blinding will not be possible after surgery. The surgeon cannot be blinded to the type of surgery. The individual analyzing the results will be blinded to patient allocation, and each surgical method will be assigned codes A and B for data analysis. Therefore, this study will be conducted as a single-blind trial (blinding only for the data analyst).
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Afzalipour Hospital-Kerman University of Medical Sciences
Street address
Medical University Campus, Haft-Bagh Highway, Kerman, Iran
City
kerman
Province
Kerman
Postal code
7616913555
Approval date
2025-09-27, 1404/07/05
Ethics committee reference number
IR.KMU.AH.REC.1404.134

Health conditions studied

1

Description of health condition studied
Acute appendicitis
ICD-10 code
K35.80
ICD-10 code description
Unspecified acute appendicitis

Primary outcomes

1

Description
Surgical site infection (SSI). Postoperative days 1, 2, 3, 4, 7, and 14 will be considered as the primary time points for outcome assessment. At these intervals, the surgical wound will be evaluated in terms of its appearance (e.g., potential discharge), blood tests (e.g., leukocyte count), and the presence of intra-abdominal abscesses using ultrasound imaging.
Timepoint
Surgical site infection (SSI). Postoperative days 1, 2, 3, 4, 7, and 14 will be considered as the primary time points for outcome assessment.
Method of measurement
The surgical wound will be evaluated in terms of its appearance (e.g., potential discharge), blood tests (e.g., leukocyte count), and the presence of intra-abdominal abscesses using ultrasound imaging.

Secondary outcomes

1

Description
surgery duration
Timepoint
By a digital clock by minute, and then entering it into a checklist
Method of measurement
Once during an appendectomy for each person

2

Description
Postoperative pain score
Timepoint
For each person, 6, 2, 12, and 24 hours after the operation
Method of measurement
Visual Analog Scale

3

Description
Frequency of use of housing until 48 hours after the operation
Timepoint
until 48 hours after the operation
Method of measurement
Using the patient record

4

Description
Start consuming food
Timepoint
Recording the time of first intake of oral fluids, recording the time of starting a soft diet or light solid food, and recording the time of complete return to a normal diet after surgery
Method of measurement
Recording the time of first intake of oral fluids, recording the time of starting a soft diet or light solid food, and recording the time of complete return to a normal diet after surgery

5

Description
Improve bowel movement
Timepoint
Recording the time of the first gas, recording the time of the first bowel movement, recording the time of hearing bowel sounds, and recording the time of food tolerance without nausea/vomiting
Method of measurement
Recording the time of the first gas, recording the time of the first bowel movement, recording the time of hearing bowel sounds, and recording the time of food tolerance without nausea/vomiting

6

Description
Recovery of physical activity
Timepoint
Record the time when you do not need help to walk or go to the bathroom
Method of measurement
Record the time when you do not need help to walk or go to the bathroom

7

Description
Length of hospital stay after surgery
Timepoint
Length of hospital stay after surgery
Method of measurement
Length of hospital stay by day and then recorded in the checklist

8

Description
Changes in white blood cells and CRP levels after surgery
Timepoint
Twice: once 24 hours after surgery and once 5 days after surgery
Method of measurement
White blood cell count and C-reactive protein level

9

Description
Postoperative quality of life
Timepoint
7 days after surgery
Method of measurement
WHO-QOL-BREF standard questionnaire

Intervention groups

1

Description
Control group: Open appendectomy (OA) performed under general anesthesia through a right lower quadrant abdominal incision using the standard open surgical technique. Skin closure is performed with appropriate sutures following routine protocols. Intervention group: Laparoscopic appendectomy (LA) performed under general anesthesia using a standard three-port laparoscopic technique for appendix dissection and removal. Skin closure is similarly done with sutures according to standard procedures. Both groups’ surgeries are conducted by the same surgical team following a unified protocol to minimize bias.
Category
Treatment - Surgery

2

Description
Intervention group: Laparoscopic appendectomy performed under general anesthesia using a standard three-port laparoscopic technique for appendix dissection and removal. The procedure follows established surgical guidelines and is conducted by a unified surgical team to minimize bias. Skin closure is done with appropriate sutures according to standard practice.
Category
Treatment - Surgery

Recruitment centers

1

Recruitment center
Name of recruitment center
Bahonar Hospital, Surgery Department
Full name of responsible person
Dr. Saheb Bahreh Bar
Street address
Bahonar Hospital, Kerman, Iran
City
kerman
Province
Kerman
Postal code
7613747181
Phone
+98 913 846 2994
Email
f.doostmohammadi2@gmail.com
Web page address

2

Recruitment center
Name of recruitment center
Afzali Pour Hospital, Surgery Department
Full name of responsible person
Dr. Alireza Amir Beigi
Street address
Afzali Pour Hospital, Kerman, Iran
City
kerman
Province
Kerman
Postal code
7619674798
Phone
+98 912 225 8432
Email
ali_amirbeigi@yahoo.com
Web page address

3

Recruitment center
Name of recruitment center
Arjmandeh Hospital, Surgery Department
Full name of responsible person
Dr. Alireza Amir Beigi
Street address
Arjmande Hospital, Kerman, Iran
City
kerman
Province
Kerman
Postal code
7613858774. Doctore
Phone
+98 34 3244 1553
Email
ali_amirbeigi@yahoo.com
Web page address

4

Recruitment center
Name of recruitment center
Mehrgan Hospital, Surgery Department
Full name of responsible person
Dr. Alireza Amir Beigi
Street address
No. 3, Shahid Kamiab St., Kerman, Iran
City
kerman
Province
Kerman
Postal code
7614613191
Phone
+98 34 9100 1818
Email
info@mehrganhospital.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Professor . Hamid Sharifi
Street address
Kerman University of Medical Sciences Vice Chancellor for Research and Technology Kerman, Iran
City
kerman
Province
Kerman
Postal code
7619813159
Phone
+98 34 3226 3725
Email
research@kmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kerman University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Fatemeh Doost Mohammadi
Position
staff
Latest degree
Ph.D.
Other areas of specialty/work
Epidemiology
Street address
Clinical Research Development Unit, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran
City
kerman
Province
Kerman
Postal code
7613747181
Phone
+98 34 3244 1553
Email
f.doostmohammadi2@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Fatemeh Doost Mohammadi
Position
reseacher staff
Latest degree
Ph.D.
Other areas of specialty/work
Epidemiology
Street address
Clinical Research Development Unit, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran
City
kerman
Province
Kerman
Postal code
7613747181
Phone
+98 34 3244 1553
Email
f.doostmohammadi2@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Fatemeh Doost Mohammadi
Position
Research staff
Latest degree
Ph.D.
Other areas of specialty/work
Epidemiology
Street address
Clinical Research Development Unit, Shahid Bahonar Hospital, Kerman University of Medical Sciences, Kerman, Iran
City
kerman
Province
Kerman
Postal code
7613747181
Phone
+98 34 3244 1553
Email
f.doostmohammadi2@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
There is no further information
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Please provide the specific title of the documents or data files to be shared and additional details about them. For example, if individual participant data (IPD) are to be shared, clarify whether all deidentified data will be shared or only a subset, such as data related to the primary outcome.
When the data will become available and for how long
Please provide information regarding the timing of the release of these documents/data files. Your description should include both the time frame and the start date of access. This can be a specific date, for example, “access will start from January 2020,” or relative timing such as “access will begin 6 months after publication of results.”
To whom data/document is available
Please specify who will be allowed to request access to the data or other study documents. For example, will your data only be available to researchers affiliated with academic institutions, or can industry professionals also apply to receive it?
Under which criteria data/document could be used
Please specify, besides the criteria for who can request the data or documents, any other conditions for using the shared data or documents. For example, what types of analyses are permitted, what kinds of use are allowed, and what mechanisms govern this access? Please list the necessary conditions for submitting requests to access the data or documents.
From where data/document is obtainable
Please guide applicants on where to apply to obtain the desired documents or data files. Applicants should know whom or where to contact to receive the requested materials. Please state preferred communication methods and provide clear contact information such as postal or email addresses, website URLs, telephone and fax numbers, as well as names and addresses of contact persons.
What processes are involved for a request to access data/document
Please provide details about the procedures that the requester must follow to obtain these documents or data files. Your description should be clear enough for the applicant to estimate how long it will take to receive the requested materials after applying.
Comments
Please provide any additional information or comments here if necessary.
Loading...